Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Kura Oncology (KURA) Receivables - Net (2024 - 2025)

Kura Oncology (KURA) has disclosed Receivables - Net for 2 consecutive years, with $8.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Receivables - Net rose 327.38% to $8.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $8.8 million, a 327.38% increase, with the full-year FY2025 number at $8.8 million, up 327.38% from a year prior.
  • Receivables - Net was $8.8 million for Q4 2025 at Kura Oncology, down from $35.9 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $48.7 million in Q1 2025 to a low of $2.1 million in Q4 2024.